Jeremy D Waight

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 2

Top Topics

Immune Response

Mesenchymal Stem Cells

Top Venues

Cancer research communications

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Dhan Chand, David A Savitsky, Shanmugarajan Krishnan, Gabriel Mednick, Chloe Delepine, Pilar Garcia-Broncano, Kah Teong Soh, Wei Wu, Margaret K Wilkens, Olga O Udartseva, Sylvia Vincent, Bishnu P Joshi, Justin G Keith, Mariana Manrique, Marilyn Marques, Antoine Tanne, Daniel L Levey, Haiyong Han, Serina Ng, Jackson Ridpath, Olivia Huber, Benjamin Morin, Claire Galand, Sean Bourdelais, Randi B Gombos, Rebecca Ward, Yu Qin, Jeremy D Waight, Matthew R Costa, Alvaro Sebastian-Yague, Nils-Petter Rudqvist, Malgorzata Pupecka-Swider, Vignesh Venkatraman, Andrew Slee, Jaymin M Patel, Joseph E Grossman, Nicholas S Wilson, Daniel D Von Hoff, Justin Stebbing, Tyler J Curiel, Jennifer S Buell, Steven J O'Day, Robert B Stein
Botensilimab, an Fc-enhanced anti-CTLA-4 antibody, is effective against tumors poorly responsive to conventional immunotherapy. Cancer discovery (2024)
Sapna Yadavilli, Jeremy D Waight, Sara Brett, Meixia Bi, Tianqian Zhang, Yao-Bin Liu, Catherine Ellis, David C Turner, Ashleigh Hahn, Hong Shi, Laura Seestaller-Wehr, Junping Jing, Qing Xie, Jafar Sadik Shaik, Xiao Ji, Robert Gagnon, William Fieles, Laura Hook, Steven Grant, Stephanie Hopley, M Phillip DeYoung, Christina Blackwell, Michael Chisamore, Robert Biddlecombe, David J Figueroa, Christopher B Hopson, Roopa Srinivasan, James Smothers, Michele Maio, Danny Rischin, Daniel Olive, Elaine Paul, Patrick A Mayes, Axel Hoos, Marc Ballas
Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade. Cancer research communications 3 (8) (2023)